ArticleFrontiers in immunology2026

Immune checkpoint inhibitor-induced diabetes mellitus in metastatic NSCLC: a case report with extended follow-up and management considerations.

Daniele Nova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.